Pharmacoepidemiology and drug safety
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Use of electronic health record data to examine administrations of pro re nata analgesics during hip fracture post-acute care..
33:-.
2024
-
Signal detection of adverse events associated with gabapentinoid use for chronic pain..
33:-.
2023
-
High-throughput screening for prescribing cascades among real world statin initiators..
32:773-782.
2023
-
Feasibility and validity of using healthcare databases to conduct cross-national comparative studies of opioid use, its determinants and consequences.
2023
-
Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System..
32:558-566.
2022
-
Applying Mixture Cure Survival Modeling to Medication Persistence Analysis..
31:788-795.
2022
-
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data..
31:467-475.
2021
-
Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade..
31:72-81.
2021
-
The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology..
30:1281-1292.
2021
-
Use of negative controls in a prescription sequence symmetry analysis to reduce time-varying bias..
30:1192-1199.
2021
-
Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology..
30:671-684.
2021
-
Trends in fall-related mortality and fall risk increasing drugs among older individuals in the United States,1999-2017..
30:1049-1056.
2021
-
Alzheimer's disease and related dementias risk: Comparing users of non-selective and M3-selective bladder antimuscarinic drugs..
29:1650-1658.
2020
-
Leveraging neuropathological data in pharmacoepidemiology: A promising approach for dementia prevention?.
30:1-3.
2020
-
Medication persistence of targeted immunomodulators for plaque psoriasis: A retrospective analysis using a U.S. claims database..
29:675-683.
2020
-
Potentially inappropriate medication prescribed among older patients in a primary care setting in Malaysia..
29:363-364.
2019
-
A retrospective analysis of reporting of adverse drug reactions over 4 years in a primary care health clinic in Malaysia..
28:1560-1561.
2019
-
National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997-2017..
28:1246-1250.
2019
-
A systematic review of methods for determining cross-sectional active medications using pharmacy databases..
28:403-421.
2019
-
Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators..
27:848-856.
2018
-
Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients..
27:660-667.
2018
-
Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infection..
27:731-739.
2018
-
Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database..
27:398-404.
2018
-
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System..
27:263-271.
2018
-
Decline in opioid prescribing after federal rescheduling of hydrocodone products..
27:513-519.
2017
-
Evaluation of algorithms to identify delirium in administrative claims and drug utilization database..
26:945-953.
2017
-
Economic impact of medication error: a systematic review..
26:481-497.
2017
-
Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study..
25:687-94.
2015
-
Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations..
23:891-901.
2014
-
Compliance after switching from branded to generic statins..
23:1093-100.
2014
-
Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study..
23:699-710.
2014
-
Methods for estimation of disparities in medication use in an observational cohort study: results from the Multi-Ethnic Study of Atherosclerosis..
22:533-41.
2013
-
Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect..
121-9.
2012
-
Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy..
21:818-27.
2012
-
Uses of proton pump inhibitors and hypomagnesemia..
21:553-9.
2012
-
Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation..
21:276-80.
2012
-
A systematic review of validated methods for identifying atrial fibrillation using administrative data..
21 Suppl 1:141-7.
2012
-
A systematic review of validated methods for identifying infection related to blood products, tissue grafts, or organ transplants using administrative data..
213-21.
2012
-
A systematic review of validated methods for identifying lymphoma using administrative data..
203-12.
2012
-
A systematic review of validated methods for identifying pancreatitis using administrative data..
194-202.
2012
-
A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data..
183-93.
2012
-
A systematic review of validated methods for identifying transfusion-related ABO incompatibility reactions using administrative and claims data..
230-5.
2012
-
A systematic review of validated methods for identifying transfusion-related sepsis using administrative and claims data..
222-9.
2012
-
Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned..
82-9.
2012
-
Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research..
90-9.
2012
-
The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction..
1-8.
2012
-
Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting..
19:1211-5.
2010
-
Central nervous system medication use and incident mobility limitation in community elders: the Health, Aging, and Body Composition study..
18:916-22.
2009
-
Uses of proton pump inhibitors and serum potassium levels..
18:865-71.
2009
-
Antivirals and antibiotics for influenza in the United States, 1995--2002..
14:531-6.
2005
-
Economic impact of medication error: a systematic review
2017
-
Economic impact of medication error: a systematic review
2017
-
Economic impact of medication error: a systematic review
2017
Identity
International Standard Serial Number (ISSN)